Arcadia Biosciences free cash flow RKDA

Cash from operations less capital spending, by quarter and over the last twelve months, from 2014.

Arcadia Biosciences' free cash flow was −$4.7M over the twelve months to Dec 31, 2025.

In its latest quarter, Q4 FY25, it was −$861K.

Free cash flow over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	Free cash flow	On a year earlier	Last 12 months
Q4 FY25	Dec 31, 2025	−$861K	n/a	−$4.7M
Q3 FY25	Sep 30, 2025	−$257K	n/a	−$6.1M
Q2 FY25	Jun 30, 2025	−$2M	n/a	−$7.6M
Q1 FY25	Mar 31, 2025	−$1.6M	n/a	−$8M
Q4 FY24	Dec 31, 2024	−$2.2M	n/a	−$9.6M
Q3 FY24	Sep 30, 2024	−$1.8M	n/a	−$11.6M
Q2 FY24	Jun 30, 2024	−$2.5M	n/a	−$12.7M
Q1 FY24	Mar 31, 2024	−$3.2M	n/a	−$15.1M
Q4 FY23	Dec 31, 2023	−$4.1M	n/a	−$15.3M
Q3 FY23	Sep 30, 2023	−$2.9M	n/a	−$13.5M
Q2 FY23	Jun 30, 2023	−$4.8M	n/a	−$14M
Q1 FY23	Mar 31, 2023	−$3.5M	n/a	−$12.6M

Companies in Oil & Gas Exploration & Production nearest Arcadia Biosciences' size, closest first, today.

Company	Free cash flow yield
RKDAArcadia Biosciences	n/m
TPETTrio Petroleum	n/m
BRNBarnwell Industries	n/m
MXCMexco Energy	7.3%
CKXCKX Lands	n/m
EONREON Resources	−38.5%
PROPPrairie Operating	n/m
AGIGAbundia Global Impact	n/m
BATLBattalion Oil	n/m
NRTNorth European Oil Royalty Trust	n/m
BSINBig Sky Industrial	−5.4%
Peer median	−5.4%